XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results | British Journal of Cancer
Cancers | Free Full-Text | Adjuvant Chemotherapy for Stage III Colon Cancer
Cancers | Free Full-Text | The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
Trials With XELOX-Based Neoadjuvant Chemoradiotherapy With or Without... | Download Table
Proposed decision algorithm for adjuvant therapy in colon cancer LN:... | Download Scientific Diagram
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study - Annals of Oncology
The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis | International Journal of Colorectal Disease
Kaplan–Meier curves of patients with stage III colon cancer in right-... | Download Scientific Diagram
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial - ScienceDirect
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology
Adjuvant treatment for colon cancer. | Download Scientific Diagram
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Table 1 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
JCM | Free Full-Text | The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
IJMS | Free Full-Text | Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer
Adjuvant chemotherapy for colorectal cancer - ScienceDirect
PPT - ESMO/ECCO Presidential Session III PowerPoint Presentation, free download - ID:5764158
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer | British Journal of Cancer
Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice - ScienceDirect
Figure 2 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
